EP Patent

EP1511516A1 — Topically applicable pharmaceutical preparation

Assigned to Takeda GmbH · Expires 2005-03-09 · 21y expired

What this patent protects

A topical pharmaceutical preparation for administering a slightly soluble PDE 4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.

USPTO Abstract

A topical pharmaceutical preparation for administering a slightly soluble PDE 4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
EP1511516A1
Jurisdiction
EP
Classification
—
Expires
2005-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Takeda GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.